Understanding Immune Blood Disorders Affecting Platelets
Official title: Molecular Mechanisms of Immune Thrombocytopenia in Transfusion Medicine
Funded at Versiti Blood Health, INC. · NIH-11158635 · Data updated 2026-11-12
This program explores how the immune system causes low platelet counts and blood clots in people of all ages, from newborns to adults.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Versiti Blood Health, INC. NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $2,553,290 |
| NIH project number | 5P01HL167668-02 |
| Project ID | NIH-11158635 on NIH RePORTER |
Who could benefit from this research
✓Could help
This research focuses on understanding immune-mediated thrombocytopenic and thrombotic disorders in fetuses, newborns, and adults.
✕Less likely to help
Patients without immune-related blood disorders or those with conditions not involving platelets or clotting may not directly benefit from this specific research.
What this research studies
Our program brings together experts to deeply understand how the immune system mistakenly attacks platelets, leading to conditions like immune thrombocytopenia and blood clots. We are looking at these conditions in babies, children, and adults to uncover the specific molecular changes that happen. This work aims to build on existing knowledge to find better ways to help patients with these challenging blood disorders. The team uses a coordinated, multi-disciplinary approach to tackle these complex issues.
Why it matters
Potential benefit: If successful, this work could lead to new ways to diagnose, treat, and prevent immune-related low platelet counts and blood clots, improving patient outcomes.
How similar studies have gone: This program builds upon decades of collaborative work and existing knowledge in platelet immunology and blood disorders, aiming for a deeper understanding.
Where this research is happening
-
Versiti Blood Health, INC.
Milwaukee, United States Active
Researchers
- Principal investigator: Newman, Peter J — Versiti Blood Health, INC.
- Study coordinator: Newman, Peter J
Related research
Other NIH-funded projects on the same topics.
-
Molecular mechanisms behind immune-related low platelets and clots in transfusion medicine
This grant supports a team of researchers to understand how immune factors cause low platelets and abnormal clots, with a focus on transfusion medicine and pediatric to adult patients.
-
Developing a new treatment for immune thrombocytopenia using a specialized enzyme
This study is testing a new treatment for people with immune thrombocytopenia (ITP) that uses a specially designed enzyme to help reduce harmful antibodies and improve platelet counts, aiming to provide a safer and more effective option than what’s currently available.
-
Understanding how platelet strength relates to bleeding risk in immune thrombocytopenia
This study is looking at how strong individual platelets are in people with immune thrombocytopenic purpura (ITP) to see if that can help doctors figure out who might be at a higher risk for bleeding and need treatment, so they can avoid giving unnecessary treatment to those who are less at risk.
-
Understanding how immune responses affect blood platelet levels
This study is looking into how the immune system affects low platelet counts and blood clotting issues, with the goal of finding better treatments for people of all ages, from newborns to adults.
-
New ideas to understand, diagnose, and treat heparin-induced thrombocytopenia
A Mayo Clinic led study will look at the different kinds of HIT antibodies to improve diagnosis and treatment for people with HIT.
-
Second-generation BLVRB inhibitors to help chemotherapy patients with low platelets
A new drug candidate is being developed to raise platelet counts in patients whose cancer treatment lowers them, reducing bleeding risk.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.